This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McMahon, L. P.
Right arrow Articles by Lawrence, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McMahon, L. P.
Right arrow Articles by Lawrence, J. C., Jr.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 2002, p. 7428-7438, Vol. 22, No. 21
0270-7306/02/$04.00+0     DOI: 10.1128/MCB.22.21.7428-7438.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

The Rapamycin-Binding Domain Governs Substrate Selectivity by the Mammalian Target of Rapamycin

Lloyd P. McMahon,1 Kin M. Choi,1 Tai-An Lin,2 Robert T. Abraham,3 and John C. Lawrence, Jr.1,4*

Departments of Pharmacology,1 Medicine, University of Virginia School of Medicine, Charlottesville, Virginia 22908,4 Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543,2 Signal Transduction Program, Burnham Institute, La Jolla, California 920373

Received 30 April 2002/ Accepted 24 July 2002

The mammalian target of rapamycin (mTOR) is a Ser/Thr (S/T) protein kinase, which controls mRNA translation initiation by modulating phosphorylation of the translational regulators PHAS-I and p70S6K. Here we show that in vitro mTOR is able to phosphorylate these two regulators at comparable rates. Both (S/T)P sites, such as Thr36, Thr45, and Thr69 in PHAS-I and the h(S/T)h site (where h is a hydrophobic amino acid) Thr389 in p70S6K, were phosphorylated. Rapamycin-FKBP12 inhibited mTOR activity. Surprisingly, the extent of inhibition depended on the substrate. Moreover, mutating Ser2035 in the rapamycin-binding domain (FRB) not only decreased rapamycin sensitivity as expected but also dramatically affected the sites phosphorylated by mTOR. The results demonstrate that mutations in Ser2035 are not silent with respect to mTOR activity and implicate the FRB in substrate recognition. The findings also impose new limitations on interpreting results from experiments in which rapamycin and/or rapamycin-resistant forms of mTOR are used to investigate mTOR function in cells.

* Corresponding author. Mailing address: Department of Pharmacology, University of Virginia Health System, P.O. Box 800735, 1300 Jefferson Park Ave., Charlottesville, VA 22908-0735. Phone: (434) 924-1584. Fax: (434) 982-3575. E-mail: jcl3p{at}virginia.edu.

Molecular and Cellular Biology, November 2002, p. 7428-7438, Vol. 22, No. 21
0022-538X/02/$04.00+0     DOI: 10.1128/MCB.22.21.7428-7438.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Yu, K., Toral-Barza, L., Shi, C., Zhang, W.-G., Lucas, J., Shor, B., Kim, J., Verheijen, J., Curran, K., Malwitz, D. J., Cole, D. C., Ellingboe, J., Ayral-Kaloustian, S., Mansour, T. S., Gibbons, J. J., Abraham, R. T., Nowak, P., Zask, A. (2009). Biochemical, Cellular, and In vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin. Cancer Res. 69: 6232-6240 [Abstract] [Full Text]  
  • Crabtree, J. S., Jelinsky, S. A., Harris, H. A., Choe, S. E., Cotreau, M. M., Kimberland, M. L., Wilson, E., Saraf, K. A., Liu, W., McCampbell, A. S., Dave, B., Broaddus, R. R., Brown, E. L., Kao, W., Skotnicki, J. S., Abou-Gharbia, M., Winneker, R. C., Walker, C. L. (2009). Comparison of Human and Rat Uterine Leiomyomata: Identification of a Dysregulated Mammalian Target of Rapamycin Pathway. Cancer Res. 69: 6171-6178 [Abstract] [Full Text]  
  • Popowski, M., Ferguson, H. A., Sion, A. M., Koller, E., Knudsen, E., Van Den Berg, C. L. (2008). Stress and IGF-I Differentially Control Cell Fate through Mammalian Target of Rapamycin (mTOR) and Retinoblastoma Protein (pRB). J. Biol. Chem. 283: 28265-28273 [Abstract] [Full Text]  
  • Shor, B., Zhang, W.-G., Toral-Barza, L., Lucas, J., Abraham, R. T., Gibbons, J. J., Yu, K. (2008). A New Pharmacologic Action of CCI-779 Involves FKBP12-Independent Inhibition of mTOR Kinase Activity and Profound Repression of Global Protein Synthesis. Cancer Res. 68: 2934-2943 [Abstract] [Full Text]  
  • Reichling, L. J., Lebakken, C. S., Riddle, S. M., Vedvik, K. L., Robers, M. B., Kopp, L. M., Bruinsma, R., Vogel, K. W. (2008). Pharmacological Characterization of Purified Recombinant mTOR FRB-Kinase Domain Using Fluorescence-Based Assays. J Biomol Screen 13: 238-244 [Abstract]  
  • Amornphimoltham, P., Patel, V., Leelahavanichkul, K., Abraham, R. T., Gutkind, J. S. (2008). A Retroinhibition Approach Reveals a Tumor Cell-Autonomous Response to Rapamycin in Head and Neck Cancer. Cancer Res. 68: 1144-1153 [Abstract] [Full Text]  
  • Fonseca, B. D., Smith, E. M., Lee, V. H.-Y., MacKintosh, C., Proud, C. G. (2007). PRAS40 Is a Target for Mammalian Target of Rapamycin Complex 1 and Is Required for Signaling Downstream of This Complex. J. Biol. Chem. 282: 24514-24524 [Abstract] [Full Text]  
  • Wang, L., Harris, T. E., Roth, R. A., Lawrence, J. C. Jr (2007). PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding. J. Biol. Chem. 282: 20036-20044 [Abstract] [Full Text]  
  • Harris, T. E., Huffman, T. A., Chi, A., Shabanowitz, J., Hunt, D. F., Kumar, A., Lawrence, J. C. Jr. (2007). Insulin Controls Subcellular Localization and Multisite Phosphorylation of the Phosphatidic Acid Phosphatase, Lipin 1. J. Biol. Chem. 282: 277-286 [Abstract] [Full Text]  
  • Reinke, A., Chen, J. C.-Y., Aronova, S., Powers, T. (2006). Caffeine Targets TOR Complex I and Provides Evidence for a Regulatory Link between the FRB and Kinase Domains of Tor1p. J. Biol. Chem. 281: 31616-31626 [Abstract] [Full Text]  
  • Wang, L., Rhodes, C. J., Lawrence, J. C. Jr. (2006). Activation of Mammalian Target of Rapamycin (mTOR) by Insulin Is Associated with Stimulation of 4EBP1 Binding to Dimeric mTOR Complex 1. J. Biol. Chem. 281: 24293-24303 [Abstract] [Full Text]  
  • Tomoo, K., Abiko, F., Miyagawa, H., Kitamura, K., Ishida, T. (2006). Effect of N-Terminal Region of eIF4E and Ser65-Phosphorylation of 4E-BP1 on Interaction between eIF4E and 4E-BP1 Fragment Peptide. J Biochem 140: 237-246 [Abstract] [Full Text]  
  • Wang, X., Beugnet, A., Murakami, M., Yamanaka, S., Proud, C. G. (2005). Distinct Signaling Events Downstream of mTOR Cooperate To Mediate the Effects of Amino Acids and Insulin on Initiation Factor 4E-Binding Proteins. Mol. Cell. Biol. 25: 2558-2572 [Abstract] [Full Text]  
  • Wan, X., Mendoza, A., Khanna, C., Helman, L. J. (2005). Rapamycin Inhibits Ezrin-Mediated Metastatic Behavior in a Murine Model of Osteosarcoma. Cancer Res. 65: 2406-2411 [Abstract] [Full Text]  
  • Weisman, R., Roitburg, I., Nahari, T., Kupiec, M. (2005). Regulation of Leucine Uptake by tor1+ in Schizosaccharomyces pombe Is Sensitive to Rapamycin. Genetics 169: 539-550 [Abstract] [Full Text]  
  • Briaud, I., Dickson, L. M., Lingohr, M. K., McCuaig, J. F., Lawrence, J. C., Rhodes, C. J. (2005). Insulin Receptor Substrate-2 Proteasomal Degradation Mediated by a Mammalian Target of Rapamycin (mTOR)-induced Negative Feedback Down-regulates Protein Kinase B-mediated Signaling Pathway in {beta}-Cells. J. Biol. Chem. 280: 2282-2293 [Abstract] [Full Text]  
  • McMahon, L. P., Yue, W., Santen, R. J., Lawrence, J. C. Jr (2005). Farnesylthiosalicylic Acid Inhibits Mammalian Target of Rapamycin (mTOR) Activity Both in Cells and in Vitro by Promoting Dissociation of the mTOR-Raptor Complex. Mol. Endocrinol. 19: 175-183 [Abstract] [Full Text]  
  • Mothe-Satney, I., Gautier, N., Hinault, C., Lawrence, J. C. Jr., Van Obberghen, E. (2004). In Rat Hepatocytes Glucagon Increases Mammalian Target of Rapamycin Phosphorylation on Serine 2448 but Antagonizes the Phosphorylation of Its Downstream Targets Induced by Insulin and Amino Acids. J. Biol. Chem. 279: 42628-42637 [Abstract] [Full Text]  
  • Hafizi, S., Wang, X., Chester, A. H., Yacoub, M. H., Proud, C. G. (2004). ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 287: H1232-H1238 [Abstract] [Full Text]  
  • Hartman, M. E., O'Connor, J. C., Godbout, J. P., Minor, K. D., Mazzocco, V. R., Freund, G. G. (2004). Insulin Receptor Substrate-2-dependent Interleukin-4 Signaling in Macrophages Is Impaired in Two Models of Type 2 Diabetes Mellitus. J. Biol. Chem. 279: 28045-28050 [Abstract] [Full Text]  
  • Choi, K. M., Barash, I., Rhoads, R. E. (2004). Insulin and Prolactin Synergistically Stimulate {beta}-Casein Messenger Ribonucleic Acid Translation by Cytoplasmic Polyadenylation. Mol. Endocrinol. 18: 1670-1686 [Abstract] [Full Text]  
  • Cheng, S. W. Y., Fryer, L. G. D., Carling, D., Shepherd, P. R. (2004). Thr2446 Is a Novel Mammalian Target of Rapamycin (mTOR) Phosphorylation Site Regulated by Nutrient Status. J. Biol. Chem. 279: 15719-15722 [Abstract] [Full Text]  
  • Mohi, M. G., Boulton, C., Gu, T.-L., Sternberg, D. W., Neuberg, D., Griffin, J. D., Gilliland, D. G., Neel, B. G. (2004). Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs. Proc. Natl. Acad. Sci. USA 101: 3130-3135 [Abstract] [Full Text]  
  • Harris, T. E., Lawrence, J. C. Jr. (2003). TOR Signaling. Sci Signal 2003: re15-re15 [Abstract] [Full Text]  
  • Choi, K. M., McMahon, L. P., Lawrence, J. C. Jr. (2003). Two Motifs in the Translational Repressor PHAS-I Required for Efficient Phosphorylation by Mammalian Target of Rapamycin and for Recognition by Raptor. J. Biol. Chem. 278: 19667-19673 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»